New Aminocoumarin Antibiotics from a Cloq‐defective Mutant of the Clorobiocin Producer Streptomyces Roseochromogenes DS12.976.

Anja Freitag,Ute Galm,Shu‐Ming Li,Lutz Heide

DOI: https://doi.org/10.1002/chin.200436209

2004-01-01

ChemInform

Abstract:For Abstract see ChemInform Abstract in Full Text.

What problem does this paper attempt to address?

New Aminocoumarin Antibiotics Derived from 4-Hydroxycinnamic Acid Are Formed after Heterologous Expression of a Modified Clorobiocin Biosynthetic Gene Cluster

Christine Anderle,Shu-Ming Li,Bernd Kammerer,Bertolt Gust,Lutz Heide

DOI: https://doi.org/10.1038/ja.2007.64

2007-01-01

Abstract:Three new aminocoumarin antibiotics, termed ferulobiocin, 3-chlorocoumarobiocin and 8′-dechloro-3-chlorocoumarobiocin, were isolated from the culture broth of a Streptomyces coelicolor M512 strain expressing a modified clorobiocin biosynthetic gene cluster. Structural analysis showed that these new aminocoumarins were very similar to clorobiocin, with a substituted 4-hydroxycinnamoyl moieties instead of the prenylated 4-hydroxybenzoyl moiety of clorobiocin. The possible biosynthetic origin of these moieties is discussed.
New Aminocoumarin Antibiotics from Genetically Engineered Streptomyces Strains.

S.-M. Li,Lutz Heide

DOI: https://doi.org/10.2174/0929867053363063

IF: 4.74

2005-01-01

Current Medicinal Chemistry

Abstract:The aminocoumarin antibiotics novobiocin, clorobiocin and coumermycin A(1) are produced by different Streptomyces strains and are potent inhibitors of DNA gyrase. The biosynthetic gene clusters of all three antibiotics have been cloned and sequenced, and the function of most genes contained therein has been elucidated. In the last years, a number of "unnatural" aminocoumarins could be generated using the genetic information for the biosynthesis of these antibiotics. The investigated enzymes of aminocoumarin biosynthesis have less-than-perfect substrate specificity, facilitating the production of new antibiotics by various methods. Several new aminocoumarins could be produced by targeted genetic manipulation in the natural producers, but also in heterologous host Streptomyces coelicolor after expression of the respective gene cluster. Mutasynthesis experiments, i. e. generation of a cloQ-defective mutant of the clorobiocin producer and feeding of 13 different structural analogs of 3-dimethylallyl-4-hydroxybenzoic acid to this mutant, allowed the isolation of 32 new aminocoumarins. These compounds contained, instead of the genuine 3-dimethylallyl-4-hydroxybenzoyl moiety, the externally added analogs as the acyl components in their structures. Production of new aminocoumarins was also achieved by chemoenzymatic synthesis in vitro. Several biosynthetic enzymes have been heterologously expressed, purified und used for chemoenzymatic synthesis. The structures of the new aminocoumarins were elucidated by NMR and mass spectroscopy. Their inhibitory activity on gyrase in vitro as well as their antibacterial activity was determined. These results give further insight into the structure-activity relationships of aminocoumarins.
Chapter 18 Aminocoumarins

Lutz Heide

DOI: https://doi.org/10.1016/s0076-6879(09)04618-7

2009-01-01

Abstract:The aminocoumarin antibiotics novobiocin, clorobiocin and coumermycin A(1) are formed by different Streptomyces strains and are potent inhibitors of bacterial gyrase. Their biosynthetic gene clusters have been analyzed in detail by genetic and biochemical investigations. Heterologous expression of these gene clusters by site-specific integration into the genome of the fully sequenced host Streptomyces coelicolor A3(2) readily results in an accumulation of the antibiotics in yields similar to the wildtype strains. In recent years, the aminocoumarins have developed into a model system for the generation of new antibiotics by genetic methods. Prior to heterologous expression in S. coelicolor, cosmids containing the complete biosynthetic clusters can be manipulated in Escherichia coli by lambda RED-mediated recombination, creating single or multiple gene replacements or gene deletions. Thereby, mutant strains are generated which are blocked in the synthesis of certain intermediates or in specific tailoring reactions. For instance, mutasynthetic experiments can subsequently be carried out to generate aminocoumarin antibiotics that contain modified acyl moieties attached to the aminocoumarin core, and chemoenzymatic synthesis can be employed for the acylation of the deoxysugar moiety of structural analogues of the aminocoumarin antibiotics. Metabolic engineering-the combination of gene deletions and foreign gene expression via replicative expression vectors-can be used to generate further structural variants of these antibiotics. These methods can be combined, allowing the generation of a wide variety of new compounds. This chapter may provide general pointers for the use of genetic methods in the generation of new antibiotics.
In Vitro and in Vivo Production of New Aminocoumarins by A Combined Biochemical, Genetic, and Synthetic Approach

U Galm,MA Dessoy,J Schmidt,LA Wessjohann,L Heide

DOI: https://doi.org/10.1016/j.chembiol.2004.01.012

2004-01-01

Chemistry & Biology

Abstract:The aminocoumarin antibiotics clorobiocin, novobiocin, and coumermycin A1 are inhibitors of bacterial gyrase. Their chemical structures contain amide bonds, formed between an aminocoumarin ring and an aromatic acyl component, which is 3-dimethylallyl-4-hydroxybenzoate in the case of novobiocin and clorobiocin. These amide bonds are formed under catalysis of the gene products of cloL, novL, and couL, respectively. We first examined the substrate specificity of the purified amide synthetases CloL, NovL, and CouL for the various analogs of the prenylated benzoate moiety. We then generated new aminocoumarin antibiotics by feeding synthetic analogs of the 3-dimethylallyl-4-hydroxybenzoate moiety to a mutant strain defective in the biosynthesis of the prenylated benzoate moiety. This resulted in the formation of 32 new aminocoumarin compounds. The structures of these compounds were elucidated using FAB-MS and 1H-NMR spectroscopy.
Draft Genome Sequence of Streptomyces Roseochromogenes Subsp. Oscitans DS 12.976, Producer of the Aminocoumarin Antibiotic Clorobiocin

Christian Rueckert,Joern Kalinowski,Lutz Heide,Alexander Kristian Apel

DOI: https://doi.org/10.1128/genomea.01147-13

2014-01-01

Genome Announcements

Abstract:ABSTRACT Streptomyces roseochromogenes subsp. oscitans DS 12.976 is the producer of the gyrase-inhibiting aminocoumarin antibiotic clorobiocin. Here, we present a draft genome sequence of this strain, in which we identified the clorobiocin gene cluster as well as an unusually high number (43) of further putative secondary metabolite clusters.
Improved mutasynthetic approaches for the production of modified aminocoumarin antibiotics.

Christine Anderle,Susanne Hennig,Bernd Kammerer,Shu-Ming Li,Ludger Wessjohann,Bertolt Gust,Lutz Heide

DOI: https://doi.org/10.1016/j.chembiol.2007.07.014

2007-01-01

Chemistry & Biology

Abstract:This study reports improved mutasynthetic approaches for the production of aminocoumarin antibiotics. Previously, the mutasynthetic production of aminocoumarins with differently substituted benzoyl moieties was limited by the substrate specificity of the amide synthetase CloL. We expressed two amide synthetases with different substrate specificity, CouL and SimL, in appropriately engineered producer strains. After feeding of precursor analogs that were not accepted by CloL, but by SimL or CouL, a range of aminocoumarins, unattainable in our previous experiments, was produced and isolated in preparative amounts. Further, we developed a two-stage mutasynthesis procedure for the production of hybrid antibiotics that showed the substitution pattern of novobiocin in the aminocoumarin moiety and that of clorobiocin in the deoxysugar moiety. The substitution pattern of the benzoyl moiety was determined by external addition of an appropriate precursor. Twenty-five aminocoumarin compounds were prepared by these methods, and their structures were elucidated with mass and 1H-NMR spectroscopy.
Aminocoumarins: Mutasynthesis, Chemoenzymatic Synthesis, And Metabolic Engineering

Lutz Heide

DOI: https://doi.org/10.1016/S0076-6879(09)04618-7

2009-01-01

Abstract:The aminocoumarin antibiotics novobiocin, clorobiocin and coumermycin A, are formed by different Streptomyces strains and are potent inhibitors of bacterial gyrase. Their biosynthetic gene clusters have been analyzed in detail by genetic and biochemical investigations. Heterologous expression of these gene clusters by site-specific integration into the genome of the fully sequenced host Streptomyces coelicolor A3(2) readily results in an accumulation of the antibiotics in yields similar to the wildtype strains.In recent years, the aminocoumarins have developed into a model system for the generation of new antibiotics by genetic methods. Prior to heterologous expression in S. coelicolor, cosmids containing the complete biosynthetic clusters can be manipulated in Escherichia coli by lambda. RED-mediated recombination, creating single or multiple gene replacements or gene deletions. Thereby, mutant strains are generated which are blocked in the synthesis of certain intermediates or in specific tailoring reactions. For instance, mutasynthetic experiments can subsequently be carried out to generate aminocoumarin antibiotics that contain modified acyl moieties attached to the aminocoumarin core, and chemoenzymatic synthesis can be employed for the acylation of the deoxysugar moiety of structural analogues of the aminocoumarin antibiotics. Metabolic engineering-the combination of gene deletions and foreign gene expression via replicative expression vectors-can be used to generate further structural variants of these antibiotics.These methods can be combined, allowing the generation of a wide variety of new compounds. This chapter may provide general pointers for the use of genetic methods in the generation of new antibiotics.
Metabolic Engineering of Aminocoumarins: Inactivation of the Methyltransferase Gene Clop and Generation of New Clorobiocin Derivatives in a Heterologous Host

A Freitag,H Rapp,L Heide,SM Li

DOI: https://doi.org/10.1002/cbic.200500019

IF: 3.2

2005-01-01

ChemBioChem

Abstract:Aminocoumarin antibiotics are highly potent inhibitors of bacterial gyrase and represent a class of antibiotics that are very suitable for the generation of new compounds by metabolic engineering. In this study, the putative methyltransferase gene cloP in the biosynthetic gene cluster of clorobiocin was inactivated. Expression of the modified gene cluster in the heterologous host Streptomyces coelicolor M512 gave three new aminocoumarin antibiotics. The structures of the new compounds were elucidated by MS and 1H NMR, and their antibacterial activities were determined. All three compounds lacked clorobiocin's methyl group at 4-OH of the deoxysugar moiety, noviose. They differed from each other in the position of the 5-methylpyrrole-2-carbonyl group, which was found to be attached to either 2-OH, 3-OH or 4-OH of noviose. Attachment at 4-OH resulted in the highest antibacterial activity. This is the first time that an aminocoumarin antibiotic acylated at 4-OH in noviose has been detected.
Combinatorial Biosynthesis, Metabolic Engineering and Mutasynthesis for the Generation of New Aminocoumarin Antibiotics

Lutz Heide,Bertolt Gust,Christine Anderle,S.-M. Li

DOI: https://doi.org/10.2174/156802608784221505

2008-01-01

Current Topics in Medicinal Chemistry

Abstract:The aminocoumarin antibiotics novobiocin, clorobiocin and coumermycin A1 are produced by different Streptomyces strains. They are potent inhibitors of bacterial gyrase and topoisomerase IV, and novobiocin has been licensed as antibiotic for clinical use (Albamycin®). They also have potential applications in oncology. The biosynthetic gene clusters of all three antibiotics have been cloned and sequenced, and the function of nearly all genes contained therein has been elucidated. Rapid and versatile methods have been developed for the heterologous expression of these biosynthetic gene clusters, and in Streptomyces coelicolor M512 as heterologous host these antibiotics were produced in yields comparable to those in the natural producer strains. λ RED-mediated homologous recombination was used for genetic modification of the gene clusters in Escherichia coli. The phage φC31 attachment site and integrase functions were introduced into the cosmid backbones and employed for stable integration of the clusters into the genome of the heterologous hosts. Modification of the clusters by single or multiple gene replacements or gene deletions resulted in the formation of numerous new aminocoumarin derivatives, providing an efficient tool for the rational generation of antibiotics with modified structure. Additionally, many new antibiotics were generated by mutasynthesis experiments, i.e. the targeted deletion of genes required for the biosynthesis of a certain structural moiety of the antibiotic, and the replacement of this moiety by structural analogs which were added to the culture broth. The diversity of new structures obtained by this approach could be expanded by further genetic modifications of the gene deletion mutants, especially by expression of heterologous biosynthetic enzymes with appropriate substrate specificity. Keywords: acyl carrier protein, Novobiocin, clorobiocin analogs, genetic manipulations, Streptomyces coelicolor
Molecular cloning and sequence analysis of the clorobiocin biosynthetic gene cluster: new insights into the biosynthesis of aminocoumarin antibiotics.

Florence Pojer,Shu-Ming Li,Lutz Heide

DOI: https://doi.org/10.1099/00221287-148-12-3901

2002-01-01

Abstract:The biosynthetic gene cluster of the aminocoumarin antibiotic clorobiocin was cloned by screening of a cosmid library of Streptomyces roseochromogenes DS 12.976 with two heterologous probes from the novobiocin biosynthetic gene cluster. Sequence analysis revealed 27 ORFs with striking similarity to the biosynthetic gene clusters of novobiocin and coumermycin A, Inactivation of a putative aldolase gene, cloR, by in-frame deletion led to the abolishment of the production of clorobiocin. Feeding of the mutant with 3-dimethylailyi-4-hydroxybenzoic acid (Ring A of clorobiocin) restored clorobiocin production. Here, it is suggested that the formation of Ring A of clorobiocin may proceed via a retro-aldol reaction catalysed by CloR, i.e. by a mechanism different from the previously elucidated benzoic acid biosynthetic pathway in Streptomyces maritimus. A comparison of the gene clusters for clorobiocin, novobiocin and coumermycin A, showed that the structural differences between the three antibiotics were reflected remarkably well by differences in the organization of their respective biosynthetic gene clusters.
Functional Analysis of Biosynthetic Genes of Aminocoumarins and Production of Hybrid Antibiotics

Shu-Ming Li,Lutz Heide

DOI: https://doi.org/10.2174/1568012043353801

2004-01-01

Abstract:The aminocoumarin antibiotics novobiocin, clorobiocin and coumermycin A1 are potent inhibitors of DNA gyrase. They compete with ATP for binding to the B subunit of this enzyme and inhibit the ATP-dependent DNA supercoiling catalysed by gyrase. Cloning, sequencing and analysis of the biosynthetic gene clusters for novobiocin, clorobiocin and coumermycin A1 revealed that the structural differences and similarities of these antibiotics are perfectly reflected by the genetic organisation of the clusters. In the last four years, the function of most of the biosynthetic genes for these antibiotics could be identified by gene inactivation experiments as well as by heterologous expression in Escherichia coli or Streptomyces lividans as His6-tag or GST-tag fusion proteins. Using the information from the biosynthetic gene clusters, more than 50 new aminocoumarin derivatives have been produced by combinatorial biosynthesis, by mutasynthesis experiments or by chemoenzymatic synthesis. The biological activities of the new aminocoumarines were evaluated against E. coli gyrase and various bacterial strains. The results showed that the acyl moieties at 3-OH as well as the methyl group at 4-OH of noviose are essential for the biological activity; the methyl group and the chlorine atom at 8-position of the coumarin ring also play an important role. Aminocoumarins with a pyrrole moiety at 2-OH instead of 3-OH showed reduced biological activity. Ring A of novobiocin and clorobiocin is also involved in the interaction with gyrase. Keywords: aminocoumarin, biosynthetic genes, chemoenzymatic synthesis, gene inactivation, gyrase inhibitor, heterologous expression, hybrid antibiotic, mutasynthesis experiments, streptomyces
Use of a Halogenase of Hormaomycin Biosynthesis for Formation of New Clorobiocin Analogues with 5-Chloropyrrole Moieties.

Lutz Heide,Lucia Westrich,Christine Anderle,Bertolt Gust,Bernd Kammerer,Joern Piel

DOI: https://doi.org/10.1002/cbic.200800186

IF: 3.2

2008-01-01

ChemBioChem

Abstract:The depsipeptide antibiotic hormaomycin, which is produced by Streptomyces griseoflavus W-384, contains a 5-chloropyrrole moiety. In the producer strain we identified the gene hrmQ that shows sequence similarity to FADH(2)-dependent halogenases. This gene was cloned and heterologously expressed in Streptomyces roseochromogenes var. oscitans DS12.976, which is the producer of the aminocoumarin antibiotic clorobiocin, which contains a 5-methylpyrrole moiety. For the present experiment, we used a mutant of this strain in which the respective pyrrole-5-methyltransferase had been inactivated. Expression of the halogenase hrmQ in this mutant strain led to the formation of two new clorobiocin derivatives that carried a 5-chloropyrrole moiety. These compounds were isolated on a preparative scale, their structures were elucidated by (1)H NMR spectroscopy and mass spectrometry, and their antibacterial activity was determined. The substrate of HrmQ is likely to be a pyrrole-2-carboxyl-S-[acyl carrier protein] thioester. If this assumption is true, this study presents the first experiment in combinatorial biosynthesis that uses a halogenase that acts on an acyl carrier protein-bound substrate.
Genetic Engineering of Antibiotic Biosynthesis for the Generation of New Aminocoumarins

Lutz Heide

DOI: https://doi.org/10.1016/j.biotechadv.2009.05.017

IF: 3.595

2008-01-01

Journal of Biotechnology

Abstract:The aminocoumarin antibiotics novobiocin, clorobiocin and coumermycin A1 are inhibitors of gyrase and highly effective antibacterial agents. Their biosynthetic gene clusters have been cloned from the respective Streptomyces producer strains, and the function of nearly all genes contained therein has been elucidated by genetic and biochemical methods. Efficient methods have been developed for the genetic manipulation and the heterologous expression of the clusters, and more than 100 new derivatives of these antibiotics have been generated by metabolic engineering, mutasynthesis and chemoenzymatic synthesis, providing a model for the power of genetic and genomic methods for the generation of new bioactive compounds.
New aminocoumarin antibiotics as gyrase inhibitors.

Lutz Heide

DOI: https://doi.org/10.1016/j.ijmm.2013.08.013

IF: 3.658

2014-01-01

International Journal of Medical Microbiology

Abstract:The aminocoumarins novobiocin, clorobiocin and coumermycin A1 are structurally related antibiotics produced by different Streptomyces strains. They are potent inhibitors of bacterial gyrase. Their binding sites and their mode of action differ from those of fluoroquinolones such as ciprofloxacin. Novobiocin has been introduced into clinical use against Staphylococcus aureus infections, and S. aureus gyrase is particularly sensitive to inhibition by aminocoumarins, while topoisomerase IV is much less sensitive. Modern genetic techniques have allowed the engineering of the producer strains, resulting in a diverse range of new aminocoumarins, including compounds which are more active than the natural antibiotics as well as a compound which is actively imported across the cell envelope of Gram-negative bacteria. A further group of aminocoumarins are the simocyclinones which bind simultaneously to two different sites of gyrase and show a completely new mode of inhibition. Both the simocyclinones and the “classical” aminocoumarins strongly inhibit the fluoroquinolone-induced activation of RecA and thereby the SOS response in S. aureus. Therefore, a combination of aminocoumarins and fluoroquinolones strongly reduced the risk of resistance development and may offer new prospects in anti-infective therapy.
Molecular Cloning and Sequence Analysis of the Clorobiocin Biosynthetic Gene Cluster: New Insights into the Biosynthesis of Aminocoumarin Antibiotics the GenBank Accession Number for the Sequence of Cosmid K1F2 is AF329398.

Florence Pojer,Shu-Ming Li,Lutz Heide

DOI: https://doi.org/10.1099/00221287-148-12-3901

2002-01-01

Microbiology

Abstract:The biosynthetic gene cluster of the aminocoumarin antibiotic clorobiocin was cloned by screening of a cosmid library of Streptomyces roseochromogenes DS 12.976 with two heterologous probes from the novobiocin biosynthetic gene cluster. Sequence analysis revealed 27 ORFs with striking similarity to the biosynthetic gene clusters of novobiocin and coumermycin A(1). Inactivation of a putative aldolase gene, cloR, by in-frame deletion led to the abolishment of the production of clorobiocin. Feeding of the mutant with 3-dimethylallyl-4-hydroxybenzoic acid (Ring A of clorobiocin) restored clorobiocin production. Here, it is suggested that the formation of Ring A of clorobiocin may proceed via a retro-aldol reaction catalysed by CloR, i.e. by a mechanism different from the previously elucidated benzoic acid biosynthetic pathway in Streptomyces maritimus. A comparison of the gene clusters for clorobiocin, novobiocin and coumermycin A(1) showed that the structural differences between the three antibiotics were reflected remarkably well by differences in the organization of their respective biosynthetic gene clusters.
An Unusual Amide Synthetase (Coul) From The Coumermycin A(1) Biosynthetic Gene Cluster From Streptomyces Rishiriensis Dsm 40489

Elisabeth Schmutz,Marion Steffensky,Jürgen Schmidt,Andrea Porzel,Shu-Ming Li,Lutz Heide

DOI: https://doi.org/10.1046/j.1432-1033.2003.03830.x

2003-01-01

European Journal of Biochemistry

Abstract:The aminocoumarin antibiotic coumermycin A(1) produced by Streptomyces rishiriensis DSM 40489 contains two amide bonds. The biosynthetic gene cluster of coumermycin contains a putative amide synthetase gene, couL, encoding a protein of 529 amino acids. CouL was overexpressed as hexahistidine fusion protein in Escherichia coli and purified by metal affinity chromatography, resulting in a nearly homogenous protein. CouL catalysed the formation of both amide bonds of coumermycin A(1), i.e. between the central 3-methylpyrrole-2,4-dicarboxylic acid and two aminocoumarin moieties. Gel exclusion chromatography showed that the enzyme is active as a monomer. The activity was strictly dependent on the presence of ATP and Mn2+ or Mg2+. The apparent K-m values were determined as 26 muM for the 3-methylpyrrole-2,4-dicarboxylic acid and 44 muM for the aminocoumarin moiety, respectively. Several analogues of the pyrrole dicarboxylic acid were accepted as substrates. In contrast, pyridine carboxylic acids were not accepted. 3-Dimethylallyl-4-hydroxybenzoic acid, the acyl component in novobiocin biosynthesis, was well accepted, despite its structural difference from the genuine acyl substrate of CouL.
Assembly and Heterologous Expression of the Coumermycin A1 Gene Cluster and Production of New Derivatives by Genetic Engineering

Manuel Wolpert,Lutz Heide,Bernd Kammerer,Bertolt Gust

DOI: https://doi.org/10.1002/cbic.200700483

IF: 3.2

2008-01-01

ChemBioChem

Abstract:Many secondary metabolites of clinical importance have been isolated from different Streptomyces species. As most of the natural producers remain difficult to handle genetically, heterologous expression of an entire biosynthetic gene cluster in a well characterised host allows improved possibilities for modifications of the desired compound by manipulation of the biosynthetic genes. However, the large size of a functional gene cluster often prevents its direct cloning into a single cosmid clone. Here we describe a successful strategy to assemble the entire coumermycin A1 biosynthetic gene cluster (38.6 kb) into a single cosmid clone by λ RED recombination technology. Heterologous expression of the reconstituted gene cluster in Streptomyces coelicolor M512 resulted in the heterologous production of coumermycin A1. Inactivation of the methyltransferase gene couO—responsible for the C‐methylation at the 8‐positions of the aminocoumarin moieties in coumermycin A1—and heterologous expression of the modified cluster resulted in an accumulation of a C‐8‐unsubstituted coumermycin A1 derivative. Subsequent expression of the halogenase gene clo‐hal from the clorobiocin gene cluster in the heterologous producer strain led to the formation of two new hybrid antibiotics, containing either one or two chlorine atoms. The identities of the new compounds were verified by LC‐MS, and their antibacterial activities were tested against Bacillus subtilis in an agar diffusion assay.
New Aminocoumarins from the Rare Actinomycete Catenulispora Acidiphila DSM 44928: Identification, Structure Elucidation, and Heterologous Production.

Judith Zettler,Haiyang Xia,Nadja Burkard,Andreas Kulik,Stephanie Grond,Lutz Heide,Alexander K Apel

DOI: https://doi.org/10.1002/cbic.201300712

2014-01-01

Abstract:Genome mining led to the discovery of a novel aminocoumarin gene cluster in the rare actinomycete Catenulispora acidiphila DSM 44928. Sequence analysis revealed the presence of genes putatively involved in export/resistance, regulation, and biosynthesis of the aminocoumarin moiety and its halogenation, as well as several genes with so far unknown function. Two new aminocoumarins, cacibiocin A and B, were identified in the culture broth of C. acidiphila. Heterologous expression of the putative gene cluster in Streptomyces coelicolor M1152 confirmed that this cluster is responsible for cacibiocin biosynthesis. Furthermore, total production levels of cacibiocins could be increased by heterologous expression and screening of different culture media from an initial yield of 4.9 mg L(-1) in C. acidiphila to 60 mg L(-1) in S. coelicolor M1152. By HR-MS and NMR analysis, cacibiocin A was found to contain a 3-amino-4,7-dihydroxycoumarin moiety linked by an amide bond to a pyrrole-2,5-dicarboxylic acid. The latter structural motif has not been identified previously in any natural compound. Additionally, cacibiocin B contains two chlorine atoms at positions 6' and 8' of the aminocoumarin moiety.
An Artificial Pathway to 3,4-Dihydroxybenzoic Acid Allows Generation of New Aminocoumarin Antibiotic Recognized by Catechol Transporters of E. coli

Silke Alt,Nadja Burkard,Andreas Kulik,Stephanie Grond,Lutz Heide

DOI: https://doi.org/10.1016/j.chembiol.2010.12.016

2011-01-01

Chemistry & Biology

Abstract:An artificial operon was synthesized, consisting of the genes for chorismate pyruvate-lyase of E. coli and for 4-hydroxybenzoate 3-hydroxylase of Corynebacterium cyclohexanicum. This operon, directing the biosynthesis of 3,4-dihdroxybenzoate, was expressed in the heterologous expression host Streptomyces coelicolor M512, together with a modified biosynthetic gene cluster for the aminocoumarin antibiotic clorobiocin. The resulting strain produced a clorobiocin derivative containing a 3,4-dihdroxybenzoyl moiety. Its structure was confirmed by MS and NMR analysis, and it was found to be a potent inhibitor of the gyrases from Escherichia coli and Staphylococcus aureus. Bioassays against different E. coli mutants suggested that this compound is actively imported by catechol siderophore transporters in the cell envelope. This study provides an example of the structure of a natural product that can be rationally modified by synthetic biology.
Production of 8′-Halogenated and 8′-Unsubstituted Novobiocin Derivatives in Genetically Engineered Streptomyces coelicolor Strains

Alessandra S. Eustáquio,Bertolt Gust,Shu-Ming Li,Stefan Pelzer,Wolfgang Wohlleben,Keith F. Chater,Lutz Heide

DOI: https://doi.org/10.1016/j.chembiol.2004.09.009

2004-01-01

Chemistry & Biology

Abstract:In the present study, we produced a hybrid antibiotic, carrying a chlorine atom instead of a methyl group at position 8 of the aminocoumarin moiety of novobiocin. This compound was not accessible by conventional gene inactivation/gene expression experiments due to difficulties in the genetic manipulation of the novobiocin producer Streptomyces spheroides. However, the desired compound was obtained after modification of the novobiocin biosynthetic gene cluster by using λ-Red-mediated recombination in Escherichia coli, followed by integration of the resulting modified cosmid into the φC31 attachment site of Streptomyces coelicolor and coexpression of the halogenase Clo-hal of clorobiocin biosynthesis. The halogenase BhaA, responsible for chlorination of tyrosyl moieties of the glycopeptide antibiotic balhimycin, was unable to functionally replace the halogenase Clo-hal, suggesting that the two enzymes have different substrate specificities.

New Aminocoumarin Antibiotics from a Cloq‐defective Mutant of the Clorobiocin Producer Streptomyces Roseochromogenes DS12.976.

New Aminocoumarin Antibiotics Derived from 4-Hydroxycinnamic Acid Are Formed after Heterologous Expression of a Modified Clorobiocin Biosynthetic Gene Cluster

New Aminocoumarin Antibiotics from Genetically Engineered Streptomyces Strains.

Chapter 18 Aminocoumarins

In Vitro and in Vivo Production of New Aminocoumarins by A Combined Biochemical, Genetic, and Synthetic Approach

Draft Genome Sequence of Streptomyces Roseochromogenes Subsp. Oscitans DS 12.976, Producer of the Aminocoumarin Antibiotic Clorobiocin

Improved mutasynthetic approaches for the production of modified aminocoumarin antibiotics.

Aminocoumarins: Mutasynthesis, Chemoenzymatic Synthesis, And Metabolic Engineering

Metabolic Engineering of Aminocoumarins: Inactivation of the Methyltransferase Gene Clop and Generation of New Clorobiocin Derivatives in a Heterologous Host

Combinatorial Biosynthesis, Metabolic Engineering and Mutasynthesis for the Generation of New Aminocoumarin Antibiotics

Molecular cloning and sequence analysis of the clorobiocin biosynthetic gene cluster: new insights into the biosynthesis of aminocoumarin antibiotics.

Functional Analysis of Biosynthetic Genes of Aminocoumarins and Production of Hybrid Antibiotics

Use of a Halogenase of Hormaomycin Biosynthesis for Formation of New Clorobiocin Analogues with 5-Chloropyrrole Moieties.

Genetic Engineering of Antibiotic Biosynthesis for the Generation of New Aminocoumarins

New aminocoumarin antibiotics as gyrase inhibitors.

Molecular Cloning and Sequence Analysis of the Clorobiocin Biosynthetic Gene Cluster: New Insights into the Biosynthesis of Aminocoumarin Antibiotics the GenBank Accession Number for the Sequence of Cosmid K1F2 is AF329398.

An Unusual Amide Synthetase (Coul) From The Coumermycin A(1) Biosynthetic Gene Cluster From Streptomyces Rishiriensis Dsm 40489

Assembly and Heterologous Expression of the Coumermycin A1 Gene Cluster and Production of New Derivatives by Genetic Engineering

New Aminocoumarins from the Rare Actinomycete Catenulispora Acidiphila DSM 44928: Identification, Structure Elucidation, and Heterologous Production.

An Artificial Pathway to 3,4-Dihydroxybenzoic Acid Allows Generation of New Aminocoumarin Antibiotic Recognized by Catechol Transporters of E. coli

Production of 8′-Halogenated and 8′-Unsubstituted Novobiocin Derivatives in Genetically Engineered Streptomyces coelicolor Strains